Zobrazeno 1 - 10
of 4 574
pro vyhledávání: '"systemic mastocytosis"'
Publikováno v:
Annals of Cardiac Anaesthesia, Vol 27, Iss 4, Pp 364-367 (2024)
We describe the case of a 72-year-old male with a history of systemic mastocytosis scheduled for on-pump aortic valve replacement for severe aortic insufficiency. Anesthesia and peri-operative management included avoidance of histamine-releasing drug
Externí odkaz:
https://doaj.org/article/b0f1edfec5f3432ca144411f3e5d54a2
Publikováno v:
Journal of Blood Medicine, Vol Volume 15, Pp 421-433 (2024)
Douglas Tremblay,1 Nicole E Wagner,2 John Mascarenhas1 1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; 2Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USACorrespondence: John Mascar
Externí odkaz:
https://doaj.org/article/f8731b288b4d4cb1a84923a97bc82925
Autor:
Matthew J. Hamilton, Loren W. Greene, Lauren M. Madigan, Sa A. Wang, Cecilia Arana Yi, Andrew Kuykendall, Tracy I. George, Mariana C. Castells
Publikováno v:
Frontiers in Allergy, Vol 5 (2024)
Systemic mastocytosis (SM) is a rare hematologic condition characterized by the proliferation and accumulation in tissue of clonal mast cells in multiple organ systems. The release of mast cell mediators in the indolent disease type and the predomina
Externí odkaz:
https://doaj.org/article/0df2721cbbf44038a9b9b3c60be1dc60
Autor:
D. I. Shikhbabaeva, O. Yu. Vinogradova, A. L. Neverova, M. M. Pankrashkina, M. V. Chernikov, E. O. Detkina, Yu. N. Kobzev, S. G. Malakho, V. V. Ptushkin
Publikováno v:
Онкогематология, Vol 18, Iss 4, Pp 78-89 (2023)
Background. Mastocytosis is a heterogeneous group of diseases that are characterized by excessive proliferation and accumulation of clonal (neoplastic) mast cells in one or more organs. Advanced variants of systemic mastocytosis (aggressive systemic
Externí odkaz:
https://doaj.org/article/b0824ac883044800950c5541dea6c7c5
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/969e126df1e54fb1ba75e217dfb0dd67
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 1, Pp 100186- (2024)
Background: Systemic mastocytosis (SM) is a clonal disorder of mast cells in which the KIT Asp816Val mutation can be detected not only in mature mast cells but also in the hematopoietic stem cell and in non–mast cell lineages. Current treatment wit
Externí odkaz:
https://doaj.org/article/c8b8ada2b082489e8126ca85d7ffb734
Autor:
N. V. Mikryukova, N. M. Kalinina
Publikováno v:
Медицинская иммунология, Vol 25, Iss 6, Pp 1289-1298 (2023)
Mast Cell Activation Syndrome (MCAS) is a severe relapsing disease requiring inpatient treatment, with clinical pattern including the features of anaphylaxis. The article presents diagnostic criteria aimed for differentiation of MCAS from similar sev
Externí odkaz:
https://doaj.org/article/00103407cccd4918aa97386806154600
Publikováno v:
JAAD Case Reports, Vol 37, Iss , Pp 119-122 (2023)
Externí odkaz:
https://doaj.org/article/7635fb0dbbd84b45a600851913790c9e
Autor:
Terrence Sun, Marin Xavier
Publikováno v:
Clinical Case Reports, Vol 12, Iss 2, Pp n/a-n/a (2024)
Key Clinical Message Low dose Avapritinib is a new medication that is a potential treatment option not just for advanced systemic mastocytosis, but also for the indolent form.
Externí odkaz:
https://doaj.org/article/aa5ab2d9964b42f4bbea97e14d9abcb1
Publikováno v:
Clinical Case Reports, Vol 11, Iss 12, Pp n/a-n/a (2023)
Key Clinical Message Additional investigations for systemic involvement should be initiated once the diagnosis of cutaneous mastocytosis has been established in an adult patient. A serum tryptase can serve as a screening test for systemic mastocytosi
Externí odkaz:
https://doaj.org/article/4ea7bf1e08ef44cf9b122ab03513e267